World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VRTXVertex Pharmaceuticals | $102.49bn | 28.54 | n/a |
REGNRegeneron Pharmaceuticals | $99.30bn | 24.85 | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
IQVIqvia Holdings | $42.51bn | 30.27 | n/a |
LONNLonza AG | CH₣38.58bn | 37.15 | 0.75% |
MRNAModerna | $40.26bn | n/a | n/a |
068270Celltrion | KR₩39tn | 48.29 | 0.27% |
ICLRIcon | $25.24bn | 36.15 | n/a |
ARGXargenx SE | €20.95bn | n/a | n/a |
BNTXBioNTech SE | $20.56bn | 20.56 | n/a |
GMABGenmab A/S | DKK135.14bn | 31.31 | n/a |
ALNYAlnylam Pharmaceuticals | $18.70bn | n/a | n/a |
NBIXNeurocrine Biosciences | $13.54bn | 38 | n/a |
EXASExact Sciences | $12.95bn | n/a | n/a |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
CRLCharles River Laboratories International | $12.43bn | 30.48 | n/a |
MEDPMedpace Holdings | $12.24bn | 44.5 | n/a |
SRPTSarepta Therapeutics | $11.53bn | n/a | n/a |
UTHRUnited Therapeutics | $10.95bn | 11.71 | n/a |
TECHBIO-TECHNE | $10.49bn | 46.35 | 0.48% |